RxSight Inc [RXST] stock is trading at $15.68, down -1.32%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RXST shares have gain 10.50% over the last week, with a monthly amount glided 6.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on May 19, 2025, when Wells Fargo upgraded its rating to a Overweight but kept the price target unchanged to $25 for it. Previously, Piper Sandler started tracking the stock with Neutral rating on April 15, 2025, and set its price target to $18. On April 09, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $16 on the stock. JP Morgan downgraded its rating to a Underweight and decreased its price target to $17 on April 04, 2025. BofA Securities downgraded its rating to a Underperform and reduced its price target to $22 on April 03, 2025. Stifel downgraded its rating to Hold for this stock on December 20, 2024, and downed its price target to $40. In a note dated December 11, 2024, Wells Fargo downgraded an Equal Weight rating on this stock and revised its target price from $56 to $42.
RxSight Inc [RXST] stock has fluctuated between $12.53 and $62.88 over the past year. Currently, Wall Street analysts expect the stock to reach $70.11 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $15.68 at the most recent close of the market. An investor can expect a potential return of 347.13% based on the average RXST price forecast.
Analyzing the RXST fundamentals
RxSight Inc [NASDAQ:RXST] reported sales of 148.31M for the trailing twelve months, which represents a growth of 28.41%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -0.23%, Pretax Profit Margin comes in at -0.17%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.1 and Total Capital is -0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.21 points at the first support level, and at 14.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.05, and for the 2nd resistance point, it is at 16.41.
Ratios To Look Out For
For context, RxSight Inc’s Current Ratio is 12.68. As well, the Quick Ratio is 11.65, while the Cash Ratio is 1.23. Considering the valuation of this stock, the price to sales ratio is 4.30, the price to book ratio is 2.28.
Transactions by insiders
Recent insider trading involved Fountain Tamara, Director, that happened on Mar 12 ’25 when 7000.0 shares were sold. Director, TAMARA R FOUNTAIN completed a deal on Mar 12 ’25 to buy 7000.0 shares. Meanwhile, Director Maniar Shweta sold 3519.0 shares on Jan 22 ’25.
